ALK and anaplastic large cell lymphoma: An interesting analysis by Krumbholz and colleagues showed that, in addition to RNA, genomic DNA can be used to track the breakpoint region in NPM/ALK+ ALCL, both from PB and plasma, and use this as an MDD marker [67].